Puma Biotechnology, Inc.

General ticker "PBYI" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $184.2M (TTM average)

Puma Biotechnology, Inc. follows the US Stock Market performance with the rate: 48.2%.

Estimated limits based on current volatility of 1.5%: low 6.29$, high 6.48$

Factors to consider:

  • Total employees count: 172 (-7.0%) as of 2024
  • Top business risk factors: Economic downturns and volatility, Public health crises, Cybersecurity threats, Product recalls, Strategic risks and growth management
  • Current price 39.9% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.12$, 4.41$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.21$, 4.55$]

Financial Metrics affecting the PBYI estimates:

  • Positive: with PPE of 4.0 at the end of fiscal year the price was very low
  • Positive: 7.54 < Operating profit margin, % of 13.44
  • Positive: Operating cash flow per share per price, % of 27.13 > 12.91
  • Negative: negative Industry operating cash flow (median)
  • Positive: Inventory ratio change, % of 0.73 <= 0.82
  • Positive: Return on assets ratio (scaled to [-100,100]) of 12.43 > 6.04
  • Positive: 42.53 < Shareholder equity ratio, % of 43.18 <= 64.17
  • Negative: negative Industry operating income (median)

Similar symbols

Short-term PBYI quotes

Long-term PBYI plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $235.64MM $230.47MM
Operating Expenses $203.00MM $199.50MM
Operating Income $32.64MM $30.97MM
Non-Operating Income $-9.97MM $-6.87MM
Interest Expense $13.33MM $12.45MM
R&D Expense $50.38MM $54.94MM
Income(Loss) $22.67MM $24.10MM
Taxes $1.08MM $-6.18MM
Profit(Loss)* $21.59MM $30.28MM
Stockholders Equity $53.44MM $92.12MM
Inventory $7.08MM $8.72MM
Assets $230.53MM $213.33MM
Operating Cash Flow $27.01MM $38.92MM
Capital expenditure $12.64MM $0.06MM
Investing Cash Flow $-19.12MM $-20.44MM
Financing Cash Flow $0.00MM $-33.85MM
Earnings Per Share** $0.46 $0.62

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.